Login to Your Account

Other News To Note

Thursday, May 2, 2013
• Actavis Inc., of Parsippany, N.J., and Valeant Pharmaceuticals International Inc., of Montreal, said Actavis Specialty Brands has acquired worldwide rights to Valeant's metronidazole 1.3 percent vaginal gel antibiotic, a topical antibiotic for the treatment of bacterial vaginosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription